Tower Research Capital LLC (Trc) Reviva Pharmaceuticals Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,822 shares of RVPH stock, worth $3,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,822
Previous 390
623.59%
Holding current value
$3,583
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.05 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.33 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.93 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$869,7020.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...